TrialInternational journal of clinical oncology2019

Efficacy and safety of ramucirumab plus modified FOLFIRI for metastatic colorectal cancer.

Tomoyasu Yoshihiro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.